These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39281376)

  • 21. Combined Use of Shear Wave Elastography, Microvascular Doppler Ultrasound Technique, and BI-RADS for the Differentiation of Benign and Malignant Breast Masses.
    Wang B; Chen YY; Yang S; Chen ZW; Luo J; Cui XW; Dietrich CF; Yi AJ
    Front Oncol; 2022; 12():906501. PubMed ID: 35686093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American college of radiology ovarian-adnexal reporting and data system ultrasound (O-RADS): Diagnostic performance and inter-reviewer agreement for ovarian masses in children.
    Wang H; Wang L; An S; Ma Q; Tu Y; Shang N; Pan Y
    Front Pediatr; 2023; 11():1091735. PubMed ID: 36969276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Nomogram Based on Multimodality Ultrasonography Images for Differentiating Malignant from Benign American College of Radiology Thyroid Imaging, Reporting and Data System (TI-RADS) 3-5 Thyroid Nodules.
    Pang L; Yang X; Zhang P; Ding L; Yuan J; Liu H; Liu J; Gong X; Yu M; Luo W
    Ultrasound Med Biol; 2024 Apr; 50(4):557-563. PubMed ID: 38262884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.
    Jha P; Gupta A; Baran TM; Maturen KE; Patel-Lippmann K; Zafar HM; Kamaya A; Antil N; Barroilhet L; Sadowski EA
    JAMA Netw Open; 2022 Jun; 5(6):e2216370. PubMed ID: 35679042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI Evaluation and Characterization of Ovarian Lesions Based on Ovarian-Adnexal Reporting and Data System MRI.
    Lamghare P; Paidlewar S; Arkar R; Rangankar V; Sharma O; Julakanti S; Pandey A
    Cureus; 2024 Aug; 16(8):e67904. PubMed ID: 39328653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability of ultrasound ovarian-adnexal reporting and data system amongst less experienced readers before and after training.
    Katlariwala P; Wilson MP; Pi Y; Chahal BS; Croutze R; Patel D; Patel V; Low G
    World J Radiol; 2022 Sep; 14(9):319-328. PubMed ID: 36186517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
    Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
    Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Utility of the Fifth Edition of the BI-RADS Ultrasound Lexicon in Category 4 Breast Lesions: A Prospective Multicenter Study in China.
    Gu Y; Tian JW; Ran HT; Ren WD; Chang C; Yuan JJ; Kang CS; Deng YB; Wang H; Luo BM; Guo SL; Zhou Q; Xue ES; Zhan WW; Zhou Q; Li J; Zhou P; Zhang CQ; Chen M; Gu Y; Xu JF; Chen W; Zhang YH; Wang HQ; Li JC; Wang HY; Jiang YX
    Acad Radiol; 2022 Jan; 29 Suppl 1():S26-S34. PubMed ID: 32768352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification for adnexal masses: a systematic review and meta-analysis.
    Yi YY; Li C; Zhu WJ; Hou YL
    Clin Radiol; 2024 Sep; 79(9):e1167-e1175. PubMed ID: 38942707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of the gynecology imaging reporting and data system (GI-RADS) with the ovarian malignancy marker CA-125 in preoperative adnexal tumor assessment.
    Migda M; Bartosz M; Migda MS; Kierszk M; Katarzyna G; Maleńczyk M
    J Ovarian Res; 2018 Nov; 11(1):92. PubMed ID: 30390688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
    Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
    BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of O-RADS, GI-RADS, and ADNEX for Diagnosis of Adnexal Masses: An External Validation Study Conducted by Junior Sonologists.
    Lai HW; Lyu GR; Kang Z; Li LY; Zhang Y; Huang YJ
    J Ultrasound Med; 2022 Jun; 41(6):1497-1507. PubMed ID: 34549454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced ultrasound and shear wave elastography in the diagnosis of ACR TI-RADS 4 and 5 category thyroid nodules coexisting with Hashimoto's thyroiditis.
    Wang B; Ou X; Yang J; Zhang H; Cui XW; Dietrich CF; Yi AJ
    Front Oncol; 2022; 12():1022305. PubMed ID: 36713579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features.
    Wu M; Cai S; Zhu L; Yang D; Huang S; Huang X; Tang Q; Guan Y; Rao S; Zhou J
    Abdom Radiol (NY); 2024 Aug; ():. PubMed ID: 39164457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy.
    Yuan K; Huang YJ; Mao MY; Li T; Wang SJ; He DN; Liu WF; Li MX; Zhu XM; Chen XY; Zhu YX
    Radiology; 2023 Aug; 308(2):e223003. PubMed ID: 37552073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.